Share

April 2013; 3 (2) Five New Things

Neurocysticercosis

Five new things

Arturo Carpio, Agnès Fleury, W. Allen Hauser
First published April 15, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e31828d9f17
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
790

Share

Article Information

vol. 3 no. 2 118-125
DOI: 
https://doi.org/10.1212/CPJ.0b013e31828d9f17
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published April 15, 2013.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Arturo Carpio, MD*,
    2. Agnès Fleury, MD, PhD* and
    3. W. Allen Hauser, MD*
  1. Arturo Carpio, MD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Agnès Fleury, MD, PhD* and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. CONACYT, 2008-1-86527, PI, 2009-2012 CONACYT, 2008-106154, PI, 2009-2013

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. W. Allen Hauser, MD*
    4. Scientific Advisory Boards:

    1. DSMB NINDS neurocysticercosis treatment DSMB Cephalon

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial board Acta Neurologica Scandinavia 2000 present Editorial board Neuroepidemiology 2005 present Editorial board Epilepsy Research 2000 present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Emeritus Professor, Columbia University

    Consultancies:

    1. 1. Pfizer, Consultant, 2010 2. Neuropace Consultant 2011

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Developmental disabilities in Children with epilepsy PI David Lindenbaum, University of Kansas, Lawrence. Consultant CDC 2008-2011 INCIDENCE AND PROGNOSIS OF EPILEPSY IN HARLEM, NY: CDC PI: Dale Hesdorffer Grant #: 1 U48 DP001916-01 coinvestigator S109/30/09 - 09/29/14 FAA consultant neurologist

    Research Support, Academic Entities:

    1. Mayo Clinic, Senior Visiting Scientist, 1984 present

    Research Support, Foundations and Societies:

    1. Hotchkiss Neurological Institute, external reviewer 2008- 2010

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. FAA Consultant

  1. Research Department (AC), University of Cuenca, Cuenca, Ecuador; G.H. Sergievsky Center (AC, WAH), Faculty of Medicine, Columbia University, New York, NY; and Instituto de Investigaciones Biomédicas (AF), UNAM Instituto Nacional de Neurologia y Neurocirugía, SS, Mexico City, Mexico.
  1. Correspondence to:
    arturocarpio{at}etapanet.net
View Full Text

Article usage

Article usage: April 2013 to July 2022

AbstractFullPdfSource
Apr 20135444569Highwire
May 20134741729Highwire
Jun 20132152627Highwire
Jul 20131541312Highwire
Aug 20139427Highwire
Sep 20138445Highwire
Oct 20139135Highwire
Nov 20137864Highwire
Dec 20136024Highwire
Jan 20145414Highwire
Feb 20144901Highwire
Mar 20144201Highwire
Apr 20145002Highwire
May 20146673Highwire
Jun 20143511Highwire
Jul 20143510Highwire
Aug 20143401Highwire
Sep 20145242Highwire
Oct 20145211Highwire
Nov 20143203Highwire
Dec 20142700Highwire
Jan 20154507Highwire
Jan 20150168pmc
Feb 20154102Highwire
Feb 20150166pmc
Mar 20155202Highwire
Mar 201501911pmc
Apr 20152204Highwire
Apr 20150229pmc
May 20153512Highwire
May 20150124pmc
Jun 20153111Highwire
Jun 201501010pmc
Jul 20152303Highwire
Jul 2015052pmc
Aug 20152502Highwire
Aug 20150137pmc
Sep 20153505Highwire
Sep 20150198pmc
Oct 20153911Highwire
Oct 20150179pmc
Nov 20153301Highwire
Nov 20150288pmc
Dec 20153503Highwire
Dec 20150164pmc
Jan 20163631Highwire
Jan 20160125pmc
Feb 20163111Highwire
Feb 20160106pmc
Mar 20162303Highwire
Mar 20160146pmc
Apr 20162312Highwire
Apr 20160135pmc
May 20164901Highwire
May 201602113pmc
Jun 20162303Highwire
Jun 20160265pmc
Jul 20161600Highwire
Jul 20160185pmc
Aug 20162400Highwire
Aug 20160105pmc
Sep 20161700Highwire
Sep 20160163pmc
Oct 20163111Highwire
Oct 20160142pmc
Nov 20163511Highwire
Nov 20160156pmc
Dec 20162301Highwire
Dec 2016072pmc
Jan 20171600Highwire
Jan 2017094pmc
Feb 20171811Highwire
Feb 20170118pmc
Mar 20174611Highwire
Mar 20170216pmc
Apr 20174101Highwire
Apr 201721110pmc
May 20173603Highwire
May 201751312pmc
Jun 20172300Highwire
Jun 20175914pmc
Jul 20171901Highwire
Jul 201741416pmc
Aug 20171900Highwire
Aug 201752123pmc
Sep 20172602Highwire
Sep 201762122pmc
Oct 20171801Highwire
Oct 20170810pmc
Nov 20171600Highwire
Nov 201741416pmc
Dec 20171721Highwire
Jan 20181960Highwire
Feb 20182951Highwire
Mar 20183620Highwire
Apr 20184921Highwire
Apr 201862327pmc
May 20186842Highwire
Jun 20184821Highwire
Jun 201833239pmc
Jul 20185100Highwire
Aug 20186630Highwire
Aug 201861719pmc
Sep 20184311Highwire
Oct 20186951Highwire
Nov 20189610Highwire
Dec 201813440Highwire
Jan 201910900Highwire
Feb 201912840Highwire
Mar 20199920Highwire
Apr 20197401Highwire
May 20196910Highwire
Jun 20195800Highwire
Jul 20195910Highwire
Aug 20195500Highwire
Sep 20195101Highwire
Oct 20196711Highwire
Nov 20199921Highwire
Dec 20197301Highwire
Jan 20208401Highwire
Feb 20207116Highwire
Mar 202064015Highwire
Apr 202061314Highwire
May 20206728Highwire
Jun 202056311Highwire
Jul 20204713Highwire
Aug 202011308Highwire
Sep 20207724Highwire
Oct 202012343Highwire
Nov 202010121Highwire
Dec 20205921Highwire
Jan 20215221Highwire
Feb 20217503Highwire
Mar 20218440Highwire
Apr 20214612Highwire
May 20213822Highwire
Jun 20214714Highwire
Jul 20215322Highwire
Aug 20215100Highwire
Sep 20214612Highwire
Oct 20215440Highwire
Nov 20212710Highwire
Dec 20212703Highwire
Jan 20225203Highwire
Feb 20225624Highwire
Mar 20223413Highwire
Apr 20223524Highwire
May 20222619Highwire
Jun 202280226Highwire
Jul 2022160021Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me